全文获取类型
| 收费全文 | 43549篇 |
| 免费 | 3122篇 |
| 国内免费 | 149篇 |
专业分类
| 耳鼻咽喉 | 292篇 |
| 儿科学 | 1475篇 |
| 妇产科学 | 1014篇 |
| 基础医学 | 5087篇 |
| 口腔科学 | 819篇 |
| 临床医学 | 4587篇 |
| 内科学 | 9268篇 |
| 皮肤病学 | 728篇 |
| 神经病学 | 4260篇 |
| 特种医学 | 1396篇 |
| 外科学 | 6434篇 |
| 综合类 | 801篇 |
| 一般理论 | 68篇 |
| 预防医学 | 3693篇 |
| 眼科学 | 1037篇 |
| 药学 | 3141篇 |
| 中国医学 | 49篇 |
| 肿瘤学 | 2671篇 |
出版年
| 2023年 | 134篇 |
| 2022年 | 199篇 |
| 2021年 | 665篇 |
| 2020年 | 423篇 |
| 2019年 | 698篇 |
| 2018年 | 829篇 |
| 2017年 | 639篇 |
| 2016年 | 656篇 |
| 2015年 | 846篇 |
| 2014年 | 1203篇 |
| 2013年 | 1840篇 |
| 2012年 | 2777篇 |
| 2011年 | 3024篇 |
| 2010年 | 1682篇 |
| 2009年 | 1554篇 |
| 2008年 | 2749篇 |
| 2007年 | 3010篇 |
| 2006年 | 2950篇 |
| 2005年 | 3046篇 |
| 2004年 | 2877篇 |
| 2003年 | 2644篇 |
| 2002年 | 2683篇 |
| 2001年 | 517篇 |
| 2000年 | 364篇 |
| 1999年 | 511篇 |
| 1998年 | 652篇 |
| 1997年 | 498篇 |
| 1996年 | 437篇 |
| 1995年 | 395篇 |
| 1994年 | 325篇 |
| 1993年 | 325篇 |
| 1992年 | 310篇 |
| 1991年 | 298篇 |
| 1990年 | 247篇 |
| 1989年 | 270篇 |
| 1988年 | 257篇 |
| 1987年 | 233篇 |
| 1986年 | 237篇 |
| 1985年 | 248篇 |
| 1984年 | 328篇 |
| 1983年 | 268篇 |
| 1982年 | 334篇 |
| 1981年 | 291篇 |
| 1980年 | 289篇 |
| 1979年 | 185篇 |
| 1978年 | 167篇 |
| 1977年 | 169篇 |
| 1976年 | 142篇 |
| 1974年 | 148篇 |
| 1973年 | 142篇 |
排序方式： 共有10000条查询结果，搜索用时 15 毫秒
1.
Elizabeth D. Krebs Robert B. Hawkins J. Hunter Mehaffey Clifford E. Fonner Alan M. Speir Mohammed A. Quader Jeffrey B. Rich Leora T. Yarboro Nicholas R. Teman Gorav Ailawadi 《The Journal of thoracic and cardiovascular surgery》2019,157(4):1533-1542.e2
Objectives
Expedient extubation after cardiac surgery has been associated with improved outcomes, leading to postoperative extubation frequently during overnight hours. However, recent evidence in a mixed medical-surgical intensive care unit population demonstrated worse outcomes with overnight extubation. This study investigated the impact of overnight extubation in a statewide, multicenter Society of Thoracic Surgeons database.Methods
Records from 39,812 patients undergoing coronary artery bypass grafting or valve operations (2008-2016) and extubated within 24 hours were stratified according to extubation time between 06:00 and 18:00 (day) or between 18:00 and 6:00 (overnight). Outcomes including reintubation, mortality, and composite morbidity-mortality were evaluated using hierarchical regression models adjusted for Society of Thoracic Surgeons predictive risk scores. To further analyze extubation during the night, a subanalysis stratified patients into 3 groups: 06:00 to 18:00, 18:00 to 24:00, and 24:00 to 06:00.Results
A total of 20,758 patients were extubated overnight (52.1%) and were slightly older (median age 66 vs 65 years, P < .001) with a longer duration of ventilation (4 vs 7 hours, P < .001). Day and overnight extubation were associated with equivalent operative mortality (1.7% vs 1.7%, P = .880), reintubation (3.7% vs 3.4%, P = .141), and composite morbidity-mortality (8.2% vs 8.0%, P = .314). After risk adjustment, overnight extubation was not associated with any difference in reintubation, mortality, or composite morbidity-mortality. On subanalysis, those extubated between 24:00 and 06:00 exhibited increased composite morbidity-mortality (odds ratio, 1.18; P = .001) but no difference in reintubation or mortality.Conclusions
Extubation overnight was not associated with increased mortality or reintubation. These results suggest that in the appropriate clinical setting, it is safe to routinely extubate cardiac surgery patients overnight. 相似文献2.
3.
4.
5.
6.
Alan. B. Franklin Sarah N. Bevins Jeremy W. Ellis Ryan S. Miller Susan A. Shriner J. Jeffrey Root Daniel P. Walsh Thomas J. Deliberto 《Transboundary and Emerging Diseases》2019,66(2):705-714
Using data on waterfowl band recoveries, we identified spatially explicit hotspots of concentrated waterfowl movement to predict occurrence and spatial spread of a novel influenza A virus (clade 2.3.4.4) introduced from Asia by waterfowl from an initial outbreak in North America in November 2014. In response to the outbreak, the hotspots of waterfowl movement were used to help guide sampling for clade 2.3.4.4 viruses in waterfowl as an early warning for the US poultry industry during the outbreak . After surveillance sampling of waterfowl, we tested whether there was greater detection of clade 2.3.4.4 viruses inside hotspots. We found that hotspots defined using kernel density estimates of waterfowl band recoveries worked well in predicting areas with higher prevalence of the viruses in waterfowl. This approach exemplifies the value of ecological knowledge in predicting risk to agricultural security. 相似文献
7.
8.
Sebastian Mondaca Walid K. Chatila David Bates Jaclyn F. Hechtman Andrea Cercek Neil H. Segal Zsofia K. Stadler Anna M. Varghese Ritika Kundra Marinela Capanu Jinru Shia Nikolaus Schultz Leonard Saltz Rona Yaeger 《Clinical colorectal cancer》2019,18(1):e39-e52
Background
Treatment of advanced anal squamous cell cancer (SCC) is usually with the combination of cisplatin and 5-fluorouracil, which is associated with heterogeneous responses across patients and significant toxicity. We examined the safety and efficacy of a modified schedule, FOLFCIS (leucovorin, fluorouracil, and cisplatin), and performed an integrated clinical and genomic analysis of anal SCC.Patients and Methods
We reviewed all patients with advanced anal SCC receiving first-line FOLFCIS chemotherapy – essentially a FOLFOX (leucovorin, fluorouracil, and oxaliplatin) schedule with cisplatin substituted for oxaliplatin – in our institution between 2007 and 2017, and performed deep sequencing to identify genomic markers of response and key genomic drivers.Results
Fifty-three patients with advanced anal SCC (48 metastatic; 5 unresectable, locally advanced) received first-line FOLFCIS during this period; all were platinum-naive. The response rate was 48% (95% confidence interval [CI], 32.6%-63%). With a median follow-up of 41.6 months, progression-free survival and overall survival were 7.1 months (95% CI, 4.4-8.6 months) and 22.1 months (95% CI, 16.9-28.1 months), respectively. Among all patients with advanced anal SCC that underwent sequencing during the study period, the most frequent genomic alterations consisted of chromosome 3q amplification (51%) and mutations in PIK3CA (29%) and KMT2D (22%). No genomic alteration correlated with response to platinum-containing treatment. Although there were few cases, patients with human papillomavirus-negative anal SCC did not appear to benefit from FOLFCIS, and all harbored distinct genomic profiles with TP53, TERT promoter, and CDKN2A mutations.Conclusions
FOLFCIS appears effective and safe as first-line chemotherapy in patients with advanced anal SCC and represents an alternative treatment option for these patients. 相似文献9.
10.
Saisanjana Kalagara Adam E.M. Eltorai J. Mason DePasse Alan H. Daniels 《The spine journal》2019,19(1):182-185